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ABSTRACT
IMPLEMENTING NERVE BLOCKS FOR PATIENTS UNDERGOING A
BILATERAL MASTECTOMY WITH IMMEDIATE RECONSTRUCTION: A
PRACTICE CHANGE
by Corey Beene Auerswald
December 2017
Breast cancer is one of the most commonly diagnosed cancers in women. A
mastectomy is one of the first line treatments for breast cancer, but it is associated with
considerable postoperative pain. Literature suggests current methods of pain management
are ineffective and regional anesthesia can help reduce postoperative complications
following a bilateral mastectomy with immediate reconstruction. Information from the
literature review was used to inform five anesthesia providers at a rural hospital in
Mississippi about the benefits of regional anesthesia for patients having a mastectomy. A
presentation was given to anesthesia providers regarding the benefits of paravertebral
blocks (PVB) for patients undergoing a bilateral mastectomy with immediate
reconstruction. Investigator developed questionnaires were used to determine how many
times nerve blocks were provided for patients undergoing a bilateral mastectomy with
immediate reconstruction one month before and one month after the intervention.
Descriptive statistics were used to interpret the results of the questionnaires. One month
following the presentation, 20 patients at the surgery center had a bilateral mastectomy
with immediate reconstruction. All 20 of these patients received nerve blocks. Anesthesia
providers also reported these patients had less postoperative complications than patients
who did not receive a block. Although anesthesia providers at this facility implemented
ii

Pecs I, Pecs II, and serratus plane blocks instead of PVB blocks for this patient
population, results from this project show when presented with EBP, anesthesia providers
are willing to make a practice change to improve patient outcomes.

iii

ACKNOWLEDGMENTS
I would like to thank my committee chair, Dr. Story, for her knowledge and
guidance which enabled me to complete my DNP project. I would also like to thank my
other committee members, Dr. Everson and Dr. Ley, for their advice and encouragement
throughout this process. Special thanks to Dr. Runnels for supporting my DNP project,
and to Anna Barrett for all her help.

iv

DEDICATION
First, I would like to thank my husband, Chris, and my son, John Curt, for their
love, patience, and understanding while I completed my DNP project. I would also like to
thank my mother, Cindy; my mother in law, Sarah; and all my family for their support.
Special thanks to Lauren Robertson and Leanne Davis for their friendship and
selflessness when I needed them the most.

v

TABLE OF CONTENTS
ABSTRACT ........................................................................................................................ ii
ACKNOWLEDGMENTS ................................................................................................. iv
DEDICATION .................................................................................................................... v
LIST OF TABLES ............................................................................................................. ix
LIST OF ABBREVIATIONS ............................................................................................. x
CHAPTER I – INTRODUCTION ...................................................................................... 1
Background and Significance ......................................................................................... 1
Problem Statement and Needs Assessment .................................................................... 1
Clinical Question ............................................................................................................ 2
Purpose of the Project ..................................................................................................... 4
Review of Literature ....................................................................................................... 4
Postoperative Pain ....................................................................................................... 5
Postoperative Nausea and Vomiting ........................................................................... 6
Length of Stay ............................................................................................................. 7
Cancer Recurrence ...................................................................................................... 7
Other Regional Techniques Used for Breast Surgery ................................................. 8
Theoretical Framework ................................................................................................. 10
Doctor of Nursing Practice Essentials .......................................................................... 11
Summary ....................................................................................................................... 12
vi

CHAPTER II - METHODOLOGY .................................................................................. 13
Overview ....................................................................................................................... 13
Target Population .......................................................................................................... 13
Design ........................................................................................................................... 13
Design-Ethical Considerations – Protection of Human Subjects (IRB) ....................... 14
Assumptions.................................................................................................................. 15
Resource Requirements ................................................................................................ 15
Summary ....................................................................................................................... 16
CHAPTER III - RESULTS............................................................................................... 17
Overview ....................................................................................................................... 17
Statistical Analysis ........................................................................................................ 17
Summary ....................................................................................................................... 20
CHAPTER IV – DISCUSSION........................................................................................ 21
Overview ....................................................................................................................... 21
Implications................................................................................................................... 22
Limitations .................................................................................................................... 22
Recommendations ......................................................................................................... 23
Dissemination ............................................................................................................... 23
Conclusion .................................................................................................................... 24
- DNP Essentials....................................................................................... 25
vii

– Synthesis Matrix .................................................................................... 27
– Paravertebral Block Protocol ................................................................. 38
– Initial Questionnaire .............................................................................. 40
– Follow-up Questionnaire ....................................................................... 41
– IRB Approval Letter .............................................................................. 42
– Facility Approval Letter ........................................................................ 43
– Logic Model .......................................................................................... 44
REFERENCES ................................................................................................................. 47

viii

LIST OF TABLES
Table 1 Initial Questionnaire Results ................................................................................ 18
Table 2 Follow-up Questionnaire Results......................................................................... 19
Table A1 DNP Essentials.................................................................................................. 25
Table A2 Synthesis Matrix ............................................................................................... 27
Table A3 Paravertebral Block Protocol ............................................................................ 38
Table A4 Logic Model ...................................................................................................... 44

ix

LIST OF ABBREVIATIONS
CRNA

Certified Registered Nurse Anesthetist

DNP

Doctor of Nursing Practice

EBP

Evidence Based Practice

GA

General Anesthesia

HQROL

Health Related Quality of Life

LOS

Length of Stay

NK

Natural Killer

Pecs

Pectoral Nerve Block

POD

Postoperative Day

PONV

Postoperative Nausea and Vomiting

PVB

Paravertebral Block

x

CHAPTER I – INTRODUCTION
Background and Significance
Breast cancer is one of the most commonly diagnosed cancers in women. In the
United States, breast cancer alone is expected to account for 30% all new cancer
diagnoses in women (American Cancer Society [ACS], 2017). In 2017, approximately
252,710 new cases of invasive breast cancer will be diagnosed in women, as well as an
estimated 63,410 additional cases of in situ breast cancer. Mississippi is expected to have
2340 new breast cancer diagnosis in 2017 (ACS, 2017).
A mastectomy is one of the first-line surgical treatments for breast cancer
(Steiner, Weiss, Barrett, Fingar, & Davis, 2016). Recently, mastectomy rates increased,
especially among younger women. Most patients with breast cancer having a mastectomy
will require an overnight stay for management of pain, nausea, and vomiting (Boughey et
al., 2009). Furthermore, patients undergoing a bilateral mastectomy with immediate
reconstruction experience longer hospital stays and more postoperative complications
than patients undergoing a unilateral mastectomy (Sharpe et al., 2014).
Problem Statement and Needs Assessment
A mastectomy is associated with considerable postoperative pain. Approximately
40% of mastectomy patients experience significant acute postoperative pain, indicating
current methods of treating postoperative pain are not effective (Schnabel, Reichl,
Kranke, Pogatzki-Zahn, & Zhan, 2010). Additionally, “acute postoperative pain is an
important risk factor for the development of persistent chronic postoperative pain in
women after breast surgery” (Schnabel et al., 2010, p 8). The use of general anesthetics
can cause significant postoperative nausea and vomiting (PONV), and opioid use after
1

surgery is associated with respiratory depression, nausea, and vomiting. Several studies
and anesthesia textbooks also suggest surgical stress, general anesthetics, and opioids can
decrease immune function and lead to cancer recurrence (Butterworth, Mackey, &
Wasnick, 2013; Exadaktylos, Buggy, Moriarty, Mascha, & Sessler, 2006; Fodale,
D’Arrigo, Triolo, Mondello, & La Torre, 2010). Regional anesthesia can reduce
postoperative complications for patients undergoing a bilateral mastectomy with
immediate reconstruction. However, an informal survey comprised of seven staff
certified registered nurse anesthetist (CRNAs) conducted by the investigator at various
hospitals in Mississippi revealed these anesthesia providers were unaware of these
benefits. Also, several of these CRNAs expressed a desire to learn about regional
anesthesia for this patient population.
Clinical Question
Will anesthesia providers who have received information about paravertebral
blocks (PVBs) make a practice change to incorporate PVBs into the plan of care for
patients undergoing a bilateral mastectomy with immediate reconstruction 1 month after
receiving the information? Regional anesthesia is currently used for various surgical
procedures and can be the sole anesthetic or used in combination with general anesthesia
(GA). A PVB is a type of regional nerve block which can provide postoperative pain
control for patients undergoing a mastectomy. Administration of a PVB requires
injections at each vertebral level that corresponds to the dermatome needing be
anesthetized. For example, “a simple mastectomy would require blocks at levels T3-6; for
axillary node dissection, additional injections should be made from C7 through T2”
(Butterworth et al., 2013, p. 1019). PVBs can provide analgesia, reduce the stress
2

response to surgery, and decrease the need for opioids and general anesthetic
requirements. Other benefits, such as, improved postoperative pulmonary function,
decreased incidence of chronic pain, and decreased cancer recurrence may be attributed
to PVBs (Aufforth et al., 2012; Boughey et al., 2009; Exadaktylos et al., 2006).
Recently, utilization of PVBs for breast surgery increased (Bolin, Harvey, &
Wilson, 2015). Hospitals such as the Mayo Clinic, MD Anderson, and Duke University
Hospital use PVBs routinely, when appropriate, for patients having a mastectomy (Penne,
2009). Dr. Goravanchi, a physician at MD Anderson, stated:
For patients who get the paravertebral block, we see a dramatic reduction in the
pain medication they take after surgery, thus eliminating the many side effects
that come with that. Plus, patients are often less anxious going into surgery
because they know they will wake up virtually pain-free and go home that way
(Penne, 2009, para. 19).
Although a PVB can provide many benefits, there are some risks. These risks
include hypotension, pneumothorax, block failure, and epidural spread. According to
Bolin et al. (2015), a pneumothorax is frequently the most dreaded complication of a
PVB, but the incidence of developing a pneumothorax after a PVB is only 0.5%. The
incidence of hypotension is reported to be 2-5% (Cheng & Ilfeld, 2016). However, the
use of an ultrasound machine can enhance the safety and improve the quality of the
block. Overall, PVBs are generally considered a low risk procedure, and the majority of
complications are often resolved within 24 hours.

3

Purpose of the Project
The primary goal of this project was to create a practice change in which
anesthesia providers incorporate PVBs into the plan of care for patients undergoing a
bilateral mastectomy with immediate reconstruction. Informing anesthesia providers
about the impact of postoperative complications in this population and providing
education regarding the benefits regional anesthesia offers can create an awareness that a
practice change needs to be made. Providing onsite training can further increase the
likelihood PVBs will be performed for these patients.
A secondary goal of this project was to improve postoperative outcomes for
patients undergoing a bilateral mastectomy with immediate reconstruction. A bilateral
mastectomy with immediate reconstruction is associated with more complications than a
unilateral mastectomy and an increased incidence of chronic pain or post mastectomy
pain syndrome (Kahn, 2011; Sharpe et al., 2014). In bilateral mastectomy patients, “69%
reported pain at 2 years, which affected sleep in 36% and daily activities in 22%”, and the
women who are affected the greatest by chronic pain are the ones who opt for a
contralateral mastectomy (Kahn, 2011, p. 2134). Several studies have reported the
effectiveness of PVB in decreasing postoperative complications in this population. If
implemented, PVBs can improve patient satisfaction, increase revenue, and decrease cost
to the facility.
Review of Literature
An initial literature search was performed using PubMed and Primo at The
University of Southern Mississippi in order to obtain articles involving patients
undergoing a mastectomy, PVBs, and postoperative outcomes. Search terms used were
4

mastectomy, nerve block, postoperative, pain, nausea, and vomiting. Of the 17 articles
located using PubMed, 12 were within published within the last 10 years. This number
was further reduced to five articles due to relevance. Thirteen articles published within
the last 10 years were found using Primo. Six of these articles were duplicates of the
PubMed search and six were not relevant. A total of six articles were reviewed from this
initial search. These articles revealed PVBs were most beneficial to patients having more
extensive surgery, such as a bilateral mastectomy with immediate reconstruction. This
finding led to a change in the focus of the project from mastectomy patients to patients
undergoing a bilateral mastectomy with immediate reconstruction. Additional searches of
Academic Premiere, Health Source, MEDLINE, CINAHL, and PubMed using
combinations of the terms bilateral mastectomy, mastectomy or breast surgery,
paravertebral block, postoperative, chronic pain, pain, and cancer recurrence resulted in
the discovery of 12 new relevant articles. These articles can be found in the synthesis
matrix (Appendix B).
Postoperative Pain
Studies conducted by Beyaz, Ergonenc, Altintoprak, & Erdem (2012);
Bhuvanseswari, Wig, Mathew, & Singh (2012); Boughey et al., (2009); Parikh, Sharma,
Guffey, & Myckatyn (2016); Pei et al. (2015); Schnabel et al. (2010); Tahiri et al.
(2011); and Terkawi et al. (2015) included various types of mastectomies and showed
less postoperative pain for patients in the group receiving a PVB compared to those who
did not receive a PVB. Agarwal et al. (2015) discovered for patients undergoing a
unilateral or bilateral mastectomy those in the PVB group experienced less postoperative
pain immediately, but not on postoperative day (POD) 1 when compared to those who
5

did not receive a PVB. In another study, patients in the PVB group had less postoperative
pain scores than the non-PVB group, but no statistical significance was found (Shimizu et
al., 2015). Nine studies found patients in the PVB group used less pain medications
postoperatively (Aufforth et al., 2012; Beyaz et al., 2012; Fahy et al., 2014; Glissmyer et
al., 2015; Parikh et al., 2016; Schnabel et al., 2010; Tahiri et al., 2011; Terkawi et al.,
2015). Furthermore, the greatest reduction in narcotic use was seen in patients
undergoing immediate reconstruction (Fahy et al., 2014; Parikh et al., 2016). Patients
receiving a PVB were converted to oral narcotics sooner (Coopey et al., 2013; Parikh et
al., 2016) and required less intraoperative opioids and general anesthetics (Pei et al.,
2015; Shimizu et al., 2015; Terkawi et al., 2015). Two of the studies did not address
postoperative pain (Exadaktylos et al., 2006; Fodale et al., 2014).
Six studies reported less chronic pain after a mastectomy with a PVB. Patients
receiving a PVB reported 20- 50% reduction in chronic pain (Beyaz et al., 2012). Metaanalyses by Schnabel et al. (2010) and Terkawi et al. (2015), revealed the relative risk for
chronic pain was lower in the PVB group 6 months after surgery. Bolin et al. (2015);
Schnabel et al. (2010); Shimizu et al. (2015) discovered less chronic pain 12 months after
surgery in patients who received GA in addition to a PVB. Karmakar et al., (2014)
concluded patients who receive a PVB report less severe chronic pain, exhibit fewer
symptoms and signs of chronic pain, and also experience better physical and mental
health related quality of life (HQROL).
Postoperative Nausea and Vomiting
Four studies noted PONV was significantly less in the PVB group (Beyaz et al.,
2012; Coopey et al., 2013; Schnabel et al., 2010; Terkawi et al., 2015). Likewise, higher
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antiemetic use was required for patients not receiving a PVB (Fahy et al., 2014).
Aufforth et al. (2015) noted slightly less PONV for the PVB group. PONV was not
statistically significant between the two groups in two of the studies (Bhuvanseswari et
al., 2012; Boughey et al., 2009). Eight of the 16 articles did not address PONV.
Length of Stay
The length of stay (LOS) for patients receiving a PVB was significantly less than
those who did not receive a PVB (Beyaz et al., 2012; Boughey et al., 2009; Coopey et al.,
2013; Glissmyer et al., 2015; Parikh et al., 2016; Terkawi et al., 2015). Boughey et al.
(2009), discovered patients having extensive breast surgery were less likely to require an
overnight stay if they received a PVB and were discharged sooner than those receiving
GA alone. Of the studies looking at chronic pain, only one reported patients in the nonPVB group were discharged sooner than the PVB group (Fahy et al., 2014). However,
this study included patients undergoing various types of mastectomies and patients
having a less extensive surgery were more likely to be discharged sooner than those
undergoing a bilateral mastectomy.
Cancer Recurrence
Surgery causes stress to the body, and studies show after surgery recurrence of
neoplastic disease can occur. “The body’s response to surgical stress causes the release of
chemical mediators, which determine the upregulation of malignant pathways, disruption
of tumor homeostasis, and promotion of cancer recurrence” (Fodale et al., 2014, p. 2).
Immune surveillance refers to the body’s ability to recognize self from non-self or the
cancer cells. The body then tries to eliminate the cancer cells. Since surgery causes
immunosuppression, some tumor cells are able to evade immune control (Fodale et al.,
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2014). Volatile anesthetics can further decrease immune function and pain can inhibit
immune surveillance. Regional anesthesia can block the body’s neuroendocrine response
to surgical stress by blocking transmission of neuronal signals to the central nervous
system. Locoregional anesthesia can help preserve natural killer (NK) cell function and
decrease the amount of GA required intraoperatively. Therefore, a PVB is associated with
lower risk of cancer recurrence (Fodale et al., 2014; Schnabel et al. 2010). Exadaktylos et
al. (2006) reported patients receiving a PVB in addition to GA group had less cancer
recurrence/metastasis (3/50) compared to the GA group (19/50). Furthermore, the PVB
with GA group had a slower time to recurrence than the GA group (Exadaktylos et al.,
2006). A multicenter randomized trial is currently being conducted in the U.S. to
determine the efficacy of PVBs in reducing cancer recurrence.
Other Regional Techniques Used for Breast Surgery
Wound Infiltration is the direct infiltration of local anesthetic at the surgical site
which avoids the complications associated with other regional techniques. However, data
from 15 randomized controlled trials (RCTs) failed to prove wound infiltration was
effective in reducing postoperative pain (Cheng & Ilfeld, 2016). Wound infusion involves
the placement of a catheter at the surgical site and allows for an infusion or boluses of
local anesthetic to be administered. Like wound infiltration, studies determined wound
infusion did not provide statistically significant benefits for breast surgery (Cheng &
Ilfeld, 2016).
Pectoral Nerve Blocks (Pecs) are an interfacial plane block and have been used as
an alternative to a PVB for simple mastectomy procedures and chest wall procedures
involving the axilla. A Pecs I block anesthetizes the pectoral nerves and can be used for
8

mastectomies that do not involve axillary node dissection (Cheng & Ilfeld, 2016). A
modified version of the Pecs I block is the Pecs II block. A Pecs II block anesthetizes the
medial and lateral pectoral nerves and the lateral branches of the intercostal nerves by
injecting local anesthetic between the pectoralis minor and anterior serratus muscles. A
Pecs II block can be used for more extensive breast surgery involving the axilla (Bolin et
al., 2015). However, only one RCT involving radical mastectomy procedures has been
concluded a Pecs block with GA reduces postoperative pain compared to GA alone. A
Pecs I and Pecs II block lack the risk of sympathectomy, which can cause hypotension
and bradycardia, and can still be performed if the patient is anticoagulated. Risks
associated with Pecs II blocks are thoracoacromial artery injection, pneumothorax, and
puncture of the axillary fascia. As of 2015, no formal studies comparing Pecs II blocks to
PVBs were identified in the literature. Unlike a PVB, Pecs I and II blocks cannot be used
as a sole anesthetic for a mastectomy (Bolin et al., 2015). This literature review found no
evidence to conclude Pecs I or II blocks were superior to PVBs for reducing
postoperative complications in patients undergoing a bilateral mastectomy with
immediate reconstruction.
A thoracic epidural infusion has been documented as an effective technique for
major breast surgery. Although, thoracic epidurals are effective in decreasing
postoperative complications, they carry more side effects than PVBs. Side effects of a
thoracic epidural include profound hypotension, headache, spinal cord injury, and spinal
cord hematoma (Bolin et al., 2015). Also, a thoracic epidural can only be used in a
hospital setting.
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Thoracic epidurals and PVBs are the only techniques confirmed to provide
reliable, effective postoperative pain relief for breast procedures, and PVBs are the only
regional technique proven to decrease post mastectomy pain within 12 months (Bolin et
al., 2015; Cheng & Ilfeld, 2016). Literature revealed Pecs blocks are becoming more
popular for chest wall procedures, but there is a lack of evidence to support they are
better than PVBs at decreasing postoperative complications in patients undergoing
extensive breast surgery. According to Bolin et al. (2015), PVBs are the “gold standard”
regional technique of choice for breast procedures when compared to other techniques.
This literature review revealed PVBs are most effective in reducing postoperative
complications, such as postoperative pain, PONV, chronic pain, and cancer recurrence,
and LOS in patients having a mastectomy with immediate reconstruction.
Theoretical Framework
The model for evidence-based practice (EBP) change, developed by Rosenwurm
and Larrabee, is the change theory that was used for this project to create a practice
change. The first step is to assess the need for a change in practice (Melnyk & FineoutOverholt, 2015, p. 288). This step includes identifying the practice problem. For this
project, the problem was a lack of awareness among anesthesia providers regarding the
evidence that PVBs can improve postoperative outcomes for patients undergoing a
bilateral mastectomy with immediate reconstruction. Moreover, the problem should be a
priority to anesthesia providers and the institution. One way to make this practice change
a priority is to inform anesthesia providers and the hospital they can bill separately for
these blocks because they are provided for postoperative pain. Therefore, providing a
PVB can increase reimbursement. Also, a PVB used in addition to GA could be cost
10

saving to the institution by decreasing the amount of narcotics used and length of stay for
patients.
Next, a review of current literature is done to identify EBP. The 3rd step involved
appraising the literature; synthesizing the evidence; and assessing the benefits, feasibility,
and risks of implementing the practice change (Melnyk & Fineout-Overholt, 2015). Step
4 of the model for EBP was designing a practice change by identifying resources, design
evaluation, and designing a plan for implementation. The new practice should be
supported by the evidence from Step 3 (Melnyk & Fineout-Overholt, 2015).
Step 5 involves implementation and evaluation of the practice change. In this step,
CRNAs and anesthesiologist at the institution would provide PVBs in addition to GA to
bilateral mastectomy patients having immediate reconstruction. The practice change
would then be evaluated to see if it is cost saving to the institution, increases revenue, and
improves patient outcomes. Finally, the practice change would be integrated and
maintained. This step also includes monitoring outcomes periodically and disseminating
results of the project outside of the institution (Melnyk & Fineout-Overholt, 2015).
Doctor of Nursing Practice Essentials
This doctoral project meets the eight Doctor of Nursing Practice (DNP) essentials
which are listed in Appendix A. The main essentials this project addressed were Essential
II, III, and VI. Essential II: Systems Thinking, Healthcare Organizations, and the
Advanced Practice Nurse Leader guides DNP nurses to assess current healthcare policies
and create policies that improve healthcare outcomes at an organizational level
(Zaccagnini & White, 2014). For example, this project aimed to create a practice change
which incorporates PVBs for patients undergoing a bilateral mastectomy in order to
11

improve postoperative outcomes. Essential III: Clinical Scholarship and Analytical
Methods for Evidence-Based Practice involves research translation and the dissemination
and implementation of new knowledge (American Association of Colleges of Nursing,
2006). A review of literature found PVBs can improve postoperative outcomes for
mastectomy patients. These findings were disseminated to CRNA’s to improve practice.
Essential VI: Interprofessional Collaboration for Improving Patient and Population
Health Outcomes was met through collaboration with physicians, anesthesiologist, and
CRNAs so that PVBs can be implemented for patients having a bilateral mastectomy
with immediate reconstruction to decrease LOS, improve postoperative outcomes, and
increase patient satisfaction.
Summary
Surgery for breast cancer is associated with a significant amount of postoperative
complications. DNP prepared nurses use nursing science to improve patient outcomes,
and this project sought to create a practice change to implement PVBs for patients
undergoing extensive breast surgery by educating anesthesia providers about the benefits
PVBs can provide to these patients. By following the steps in the model for EBP change,
nerve blocks were implemented in order to decrease postoperative complications for
patients undergoing a bilateral mastectomy with immediate reconstruction.
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CHAPTER II - METHODOLOGY
Overview
The literature review has shown PVBs are superior to other methods of regional
anesthesia and can improve postoperative outcomes for breast cancer patients undergoing
breast surgery. This project aimed to create a practice change to implement PVBs by
informing anesthesia providers about the benefits of PVBs for bilateral mastectomy
patients having immediate reconstruction. Once implemented, PVBs can fulfill the
secondary goal of this project which was to improve postoperative outcomes for those
undergoing breast cancer surgery with reconstruction.
Target Population
The target population for this study was anesthesia providers, CRNAs and
anesthesiologist, in Mississippi. The convenience sample used for this project consisted
of anesthesia providers at a 111 bed hospital in the Southern U.S. Healthcare providers
who were not an anesthesiologist or CRNA were excluded. Those excluded from the
study included registered nurses and physicians.
Design
An in-service was held for anesthesia providers at the facility detailing the
benefits of PVBs and how to perform them. The in-service included information
compiled from the literature review. Immediately following the in-service, anesthesia
providers were asked to perform PVBs for bilateral mastectomy patients undergoing
immediate reconstruction. A protocol was developed for administration of PVBs and is
included in Appendix C. Training and a step by step guide for performing PVBs was
provided from The New York School of Regional Anesthesia’s website at
13

www.nysora.com. Additional onsite training was provided by a healthcare provider
employed at the hospital with knowledge of PVBs.
Anesthesia providers were asked to complete an investigator developed
questionnaire regarding their anesthesia practice one month prior to the presentation. The
initial questionnaire can be found in Appendix D. A tally sheet was provided to the
anesthesia providers in order to track the number times they provided an anesthetic to a
patient undergoing a bilateral mastectomy with immediate reconstruction over a one
month time period. After the one month time period, an investigator created questionnaire
was administered to the anesthesia providers to determine if they had performed any type
of nerve block for patients having breast cancer surgery with immediate reconstruction.
The follow-up questionnaire can be found in Appendix E. Completion of the
questionnaire indicated informed consent to participate in the study.
Data was gathered from the tally sheet and the questionnaire. Information
obtained from the questionnaire included how many times a nerve block was provided,
whether or not the anesthesia provider felt the in-service was effective, and whether the
anesthesia provider felt the nerve blocks decreased postoperative complications.
Descriptive statistics was used to determine the percentage of anesthesia providers
changed their practice to incorporate nerve blocks.
Design-Ethical Considerations – Protection of Human Subjects (IRB)
Approval for the study was obtained from The University of Southern Mississippi
(17022302, Appendix F) and the facility (Appendix G). All questionnaires were
anonymous. Data obtained for this project will be deleted and/or shredded 6 months after
completion of graduation requirements.
14

If the nerve blocks are administered preoperatively for postoperative pain control,
extra income can be generated for the anesthesia provider and the facility. Training for
administration of PVBs required additional time for the anesthesia provider and could be
considered an inconvenience. Because the procedure was new to this facility, there could
have been a learning curve. During this time, patients could have been unsatisfied with
their anesthetic, which could reflect negatively on the anesthesia provider. On the other
hand, several sources have sited that PVBs are easy to learn, which could mean patient
satisfaction would improve. Additionally, there were potential risks to the patient
receiving a PVB, such as pneumothorax, hypotension, or failed anesthetic. However,
there is a low risk for developing these complications especially if an ultrasound machine
is used.
Assumptions
One assumption of this project was the postoperative care of bilateral mastectomy
patients’ needs to be improved, and patients would agree to have a PVB. Another
assumption was anesthesia providers will attend the in-service, and CRNAs would be
authorized by the facility to administer PVBs. A list of assumptions can be found in the
logic model (Appendix H).
Resource Requirements
Resources needed for this project included the anesthesia staff, preoperative
rooms, and operating rooms (OR) rooms. Equipment, such as monitors, an ultrasound
machine, and emergency airway equipment are needed to safely perform the blocks.
Other supplies needed include sterile gloves, skin prep solution, emergency drugs,
preoperative medications, nerve block medications, and nerve block needles. Another
15

resource required for this project was time. Administration of a PVB may require
additional time, which could initially increase operating room turnover time and
necessitate coordination between the anesthesia provider, surgeon, and OR staff.
Summary
Implementing PVBs for patients undergoing a bilateral mastectomy with
immediate reconstruction required training, time, collaboration with other healthcare
providers, and additional resources compared to current methods of anesthesia. However,
PVBs can benefit patients by reducing postoperative complications and anesthesia
providers due to additional revenue and increased patient satisfaction. Through the use of
descriptive statistics, this study determined if anesthesia providers at a surgery center in
the Southern U.S. made a practice change to incorporate PVBs into the plan of care for
patients having extensive breast surgery in order to make inferences about the population
of anesthesia providers in Mississippi.
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CHAPTER III - RESULTS
Overview
A 20-minute presentation was given to the anesthesia providers at a surgery center
in Mississippi. The presentation was held in the conference room of the surgery center in
the morning prior to any surgical cases. The sample included five of the six anesthesia
providers. Ages ranged from 32-62, and the mean age was 52.2. Years of experience as
an anesthesia provider were 6-33 with a mean of 25.2. Of the five participants, three
(60%) were female and two (40%) were male. Participants were administered a
questionnaire immediately following the presentation and again one month after the
presentation.
Statistical Analysis
Descriptive statistics were used to interpret the results of the questionnaires. All
five of the anesthesia providers who attended the presentation completed the initial
questionnaire. Two of the five (40%) participants completed the 1-month questionnaire.
Initial Questionnaire Results
Anesthesia providers were asked to provide information for the month prior to the
presentation. During this time period, a reported 22 patients had undergone a bilateral
mastectomy with immediate reconstruction at the surgery center. None of these patients
received a PVB. However, five (22.7%) of the 22 patients did receive a Pecs I, Pecs II,
and serratus plane block. These nerve blocks were performed during a one week time
period preceding the presentation. All of the anesthesia providers felt the information
presented was relevant to their practice. There was no correlation between age or gender
and administration of the nerve blocks.
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Table 1
Initial Questionnaire Results

Initial Questionnaire Results
Total
Participant

1

2

3

4

5

Age

58

62

32

50

59

Gender

M

F

M

F

F

Number of years as an
anesthesia provider

32

33

6

25

30

Number patients who
received a bilateral
mastectomy with immediate
reconstruction in the past
month
Number of patients who
received a PVB

5

5

5

3

4

22

0

0

0

0

0

0

Number of patients who
received another type of
nerve block
Was the information
presented relevant to your
practice

1

1

2

0

1

5

Yes

Yes

Yes

Yes

Yes

Follow-up Questionnaire
One month following the presentation, a reported 20 patients at the surgery center
had a bilateral mastectomy with immediate reconstruction. None of these patients
received a PVB. Twenty (100%) of the patients received a Pecs I, Pecs II, and serratus
plane block. All of these blocks were administered immediately following the induction
of anesthesia. None of the blocks were used as the sole anesthetic for a bilateral
mastectomy with immediate reconstruction. The only complication was minor skin
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irritation at the injection site in one patient (0.05%). Anesthesia providers reported
patients used less narcotics and a decrease in postoperative complications since the
implementation of the nerve blocks. All anesthesia providers who participated in the
follow-up questionnaire stated they would continue to perform nerve blocks for this
patient population. There was no correlation between age and willingness to perform
nerve blocks. However, all of the nerve blocks performed in the month following the
presentation were done by the male anesthesia providers.
Table 2
Follow-up Questionnaire Results
Follow-Up Questionnaire Results
Total
Participant

1

2

Age

58

32

Gender

M

M

Number of years as an
anesthesia provider

32

6

Number patients who received a
bilateral mastectomy with
immediate reconstruction in the
past month
Number of patients who
received a PVB

10

10

20

0

0

0

Number of patients who
received a different type of
nerve block

10

10

20
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Table 2 (continued)

If patients received another type
of nerve block, what type was
performed
Phase of Care when nerve block
was provided

Pecs I, Pecs II,
and serratus
plane block
Immediately
after induction

Pecs I, Pecs II,
and serratus plane
block
Immediately after
induction

Number of times a nerve block
was contraindicated

0

0

0

Number of patients who
experienced a complication
related to the nerve block
Will you continue to perform
Pecs I , Pecs II, and serratus
plane blocks for this patient
population

1 – minor skin
irritation at
injection site
Yes

0

1

Yes

Summary
Although this surgery center did not choose to administer PVBs, a practice
change was made to incorporate Pecs I, Pecs II, and serratus plane blocks into the plan of
care for bilateral mastectomy patients undergoing immediate reconstruction. Participants
in this study reported a decrease in immediate postoperative complications for the
patients who received these blocks. The next chapter will discuss recommendations,
implications for future practice, and the conclusion.
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CHAPTER IV – DISCUSSION
Overview
The literature review revealed current methods of pain control following a
bilateral mastectomy with immediate reconstruction to be suboptimal. The addition of
regional anesthesia to the anesthetic plan for these patients has been shown to improve
patient outcomes. Recently published articles have shown other types of nerve blocks to
be effective in reducing immediate postoperative complications for patients having breast
cancer surgery. Abdallah et al. (2017) demonstrated Pecs I and II blocks in addition to a
serratus plane block were effective in reducing postoperative narcotic use and PONV for
breast cancer patients in an ambulatory care setting. Kulhari, Bala, Bala, & Arora (2016)
compared Pecs II blocks to PVBs for patients having a modified radical mastectomy and
concluded Pecs II blocks to be just as effective as PVBs in reducing immediate
postoperative pain. However, no articles to date have been found comparing the Pecs I
and II blocks in addition to serratus plane block to PVBs for bilateral mastectomy
patients undergoing immediate reconstruction. Also, no studies have proven the Pecs
blocks or serratus plane blocks to be effective in reducing chronic postoperative pain.
This surgery center chose Pecs I, Pecs II, and serratus plane blocks over PVBs for
patients undergoing a bilateral mastectomy because of the ease of administration and low
risk of complications associated with the Pecs I, Pecs II, and serratus plane blocks. In
addition to determining whether or not a practice change was made, this project also
obtained information about how patients have been impacted by the practice change.
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Implications
One month after the presentation, regional anesthesia was implemented for all
patients undergoing a bilateral mastectomy with immediate reconstruction. Although all
the participants in the initial questionnaire expressed interest in implementing nerve
blocks for this patient population, the majority of the nerve blocks were administered by
two providers. In the follow up questionnaire, these two anesthesia providers reported
less narcotic use, less postoperative complication, and better outcomes when a Pecs I,
Pecs II, and serratus plane block were used. These results are similar to those found by
Kulhari et al. (2016). The healthcare providers at this facility determined nerve blocks to
be so beneficial; they now offer nerve blocks for all mastectomy procedures. The facility
where the nerve blocks were implemented has also begun to advertise improved pain
control following a mastectomy.
Limitations
One limitation to this study is the small sample size. Low participation for the
follow-up questionnaire was because the two providers participating in the follow-up
questionnaire administered all the nerve blocks in the month following the presentation.
An attempt was made to increase participation by providing the questionnaires during
times that were convenient for the anesthesia providers. Some of the anesthesia providers
reported on the initial questionnaire they had already begun performing Pecs I, Pecs II,
and serratus plane blocks for patients undergoing a bilateral mastectomy with immediate
reconstruction. Administration of the nerve blocks prior to the presentation and the
decision to make a practice change may have been due to the surgeon’s involvement in
the study. Ideally, the presentation would have been done prior to the surgeon’s arrival at
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the facility, but due to scheduling conflicts it was not possible to present the material at
an earlier date. Lack of materials and lack of buy in from healthcare providers and
administrators may make these results difficult to replicate. However, this project is
useful because it demonstrated that when presented with EBP, the anesthesia providers at
this facility were willing to make a practice change in order to improve patient outcomes.
Recommendations
This project ended during step 5 of Rosswurm and Larrabee’s model for change
to EBP. The next step would be to evaluate the effectiveness of the practice change, and
then determine if the practice change has been maintained. In addition to the evaluation
of this study, subsequent studies could attempt to replicate the results of this study at
another facility or with a larger sample size. Also, future studies could examine to what
extent these blocks decrease postoperative complications or if these blocks are effective
at decreasing length of stay, chronic pain, or cancer recurrence. More studies are needed
comparing other forms of relevant nerve blocks to PVBs to determine which is more
effective. This DNP project focused on implementing nerve blocks for patients
undergoing a bilateral mastectomy. A continuation of this project could be to create a
practice change at other facilities to provide nerve blocks for all types of mastectomies.
Dissemination
Results from this project will be disseminated to anesthesia providers at current
clinical sites and future sites of employment. Informal conversations have already been
held with CRNAs at a another facility that does not currently utilize nerve blocks for
mastectomy patients regarding the results of this project. Due to the outcome of this
project, CRNAs at the facility where nerve blocks are not performed expressed an interest
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in administering Pecs blocks to mastectomy patients. This project will also be
disseminated through Aquila and possibly at future conferences.
Conclusion
Although PVBs were not implemented at this facility, other nerve blocks were
incorporated into the plan of care for bilateral mastectomy patients having immediate
reconstruction. Literature shows nerve blocks can improve patient outcomes following
surgery for breast cancer. Future studies are needed to examine to what extent these block
decrease immediate postoperative complications and to determine their effectiveness in
decreasing length of stay, chronic pain, and cancer recurrence. Due to the effectiveness of
the nerve blocks at this facility, Pecs I and II blocks are now offered for all types of
mastectomies. The results from this project can be used at other facilities to implement
nerve blocks for patients at undergoing breast surgery for cancer.
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- DNP Essentials
Table A1
DNP Essentials
DNP Essentials
Essential I: Nursing Science and Theory:
Scientific Underpinnings for Practice

Clinical Implications
Theories provide a foundation for
understanding patient’s healthcare needs
and help to identify the best interventions
to meet those needs (Zaccagnini & White,
2014). The model for EBP change,
developed by Rosenwurm and Larrabee, is
a change theory that will be used
implement a practice change.
This essential guides DNP nurses to assess
current healthcare policies and create
policies that improve healthcare outcomes
at an organizational level (Zaccagnini &
White, 2014). For example, this project
aims to create a practice change to
incorporate PVBs for patients undergoing
a bilateral mastectomy in order to improve
postoperative outcomes.
Involves research translation and the
dissemination and implementation of new
knowledge (American Association of
Colleges of Nursing [AACN], 2006). A
review of literature found PVBs can
improve postoperative outcomes for
mastectomy patients (Schnabel et al.,
2010, p 8). These findings will be
disseminated to CRNA’s to improve
practice.
This essential ensures DNP nurses are
proficient in the use of healthcare
technology to “create web-based learning
or intervention tools to support and
improve patient care” (Zaccagnini &
White, 2014, p. 134). One of the goals for
this project is to create a website to inform
anesthesia providers about the benefits of
PVBs.

Essential II: Systems Thinking, Healthcare
Organizations, and the Advanced Practice
Nurse Leader

Essential III: Clinical Scholarship and
Analytical Methods for Evidence-Based
Practice

Essential IV: Information
Systems/Technology and Patient Care
Technology for the Improvement and
Transformation of Health Care
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Essential V: Healthcare Policy for Advocacy The purpose of this project is to change
in Healthcare
healthcare policy by disseminating
evidence based information to the CRNAs
at a facility in Mississippi.
Essential VI: Interprofessional Collaboration Through collaboration with physicians,
for Improving Patient and Population Health anesthesiologist, and CRNAs PVBs can be
Outcomes
implemented for patients undergoing a
bilateral mastectomy with immediate
reconstruction to decrease length of stay,
improve postoperative outcomes, and
increase patient satisfaction.
Essential VII: Clinical Prevention and
The goal of this essential is to promote
Population Health
patient health and prevent illness/disease
(AACN, 2006). Studies have shown PVBs
can decrease the incidence of chronic pain
and possibly cancer recurrence (Schnabel
et al., 2010, p 8). Educating anesthesia
providers about the benefits of PVBs can
lead to implementation PVBs and improve
the health of mastectomy patients.
Essential VIII: Traditional Advanced Practice This project meets Essential VIII by
Roles for the DNP
educating anesthesia providers on
evidence based findings in order to
improve clinical practice.
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– Synthesis Matrix
Table A2
Synthesis Matrix

Author/Year

Postoperative Pain
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Patients receiving a
PVB had significantly
lower pain scores than
patients who did not
receive a PVB
immediately after
surgery. However, at
noon on POD1 there
was not a statistically
significant decrease in
pain scores in the PVB
group.
Aufforth, R., Jain, Patients having
J., Morreale, J.,
immediate
Baumgarten, R.,
reconstruction with a
Falk, J., &
PVB used less opioids
Wessen, C. (2012). on post-op day 1 than
the non-PVB
reconstruction group.

Postoperative
Nausea/Vomiting

Agarwal, R.,
Wallace, A.,
Madison, S.,
Morgan, A.,
Mascha, E., &
Ilfeld, B. (2015,
April).

Slightly less
postoperative
nausea and
vomiting (PONV)
was noted in the
PVB group, 3.3%
compared to 4.2%
in the non-PVB
group.

Chronic Pain

Length of Stay

Cancer
Recurrence

Beyaz, S.,
Ergonenc, T.,
Altintoprak, F., &
Erdem, A. (2012,
August 27).

Bhuvanseswari,
V., Wig, J.,
Mathew, P., &
Singh, G. (2012).
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A thoracic PVB can
provide better
postoperative pain
management and
decrease opioid
consumption compared
to general anesthesia
(GA).
Intraoperatively,
patients in the 0.25%
bupivacaine + epi +
fentanyl and the 0.5%
bupivacaine + epi
groups was less than
the 0.25% bupivacaine
+epi and the group who
received no PVB.
Patients receiving a
PVB with 0.25%
bupivacaine +
epinephrine + fentanyl
and the group receiving
a PVB with 0.5%
bupivacaine + epi had
significantly better
postoperative analgesia
compared to the group
receiving GA alone.

A PVB prevents
PONV better than
GA.

PONV was not
statistically
significant

Many of the studies
demonstrated a 2050% reduction in
chronic post
mastectomy pain

PVB can
decrease the
length of
hospital stay
and increase
patient
satisfaction

Cited findings
by Exadaktylos,
A., Buggy, D.,
Moriarty, D.,
Mascha, E., &
Sessler, D.
(2006)

Bolin, E., Harvey,
N., & Wilson, S.
(2015, March 31)

Boughey, J.,
Goravanchi, F.,
Parris, R., Kee, S.,
Frenzel, J., Hunt,
K., ... Lucci, A.
(2009, SeptemberOctober).

Less chronic pain at
one, six, and 12
months reported in
patients who
received a PVB
compared to those
receiving GA alone.

29

The patients receiving a
PVB reported less pain
in the immediate
postop period which
continued until the next
day for patients
undergoing a total
mastectomy and/or
axillary node
dissection. Immediately
postop, 81% of patients
receiving a PVB
reported a pain score of
0 compared to 57% of
the non-PVB group. At
4 hours postop, 71% of
the PVB group reported
a pain score of 0
compared to 38% of
the non-PVB group. At
8 hours postop, 60% of
the PVB group and
36% of the non-PVB

The difference in
PONV was not
statistically
significant.

Length of stay
(LOS) for
patients having
a total
mastectomy or
more extensive
breast surgery
was
significantly
less for those
who received a
PVB. Patients
undergoing
extensive breast
surgery were
less likely to
require an
overnight
hospital stay if
they received a
PVB.

group reported a pain
score of 0.
Coopey, S.,
Specht, M.,
Warren, L., Smith,
B., Winograd, J.,
& Fleischmann, K.
(2013, April).

The PVB group was
converted to oral
narcotics sooner than
the non-PVB group.

Incidence of nausea
and vomiting was
significantly less in
the PVB group
compared to the
non-PVB group.

Mean LOS was
significantly
less in the PVB
group, which
was 42 hours
compared to 47
hours in the
non-PVB
group.
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Exadaktylos, A.,
Buggy, D.,
Moriarty, D.,
Mascha, E., &
Sessler, D. (2006,
October).

Fahy, A., Jakub, J., Although no difference
Dy, B., Eldin, N.,
in pain scores was

Patients in the
PVB with GA
group had less
cancer
recurrence/
metastasis
(3/50)
compared to the
GA group
(19/50).
Additionally,
the PVB with
GA group had a
slower time to
recurrence than
the GA group.
The amount of
patients requiring

Patients in the
non-PVB group

Harmsen, S.,
Sviggum, H., &
Boughey, J. (2014,
October)

Fodale, D’Arrigo,
Triolo, Mondello,
& La Torre. (2014)

noted on the day of
surgery, opioid uses
was higher in the nonPVB group. Patients
undergoing immediate
reconstruction had the
greatest reduction in
postoperative opioid
use.

postoperative
antiemetics was
higher in the nonPVB group (57%)
compared to the
PVB group (39%).

were discharged
sooner than the
PVB group.
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Surgery is
stressful and
studies show
after surgery
recurrence of
neoplastic
disease can
occur. Volatile
anesthetics can
decrease
immune
function and
pain can
prevent immune
surveillance,
and opioids can
inhibit cellular
and humoral
immunity.
Regional
anesthesia can
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block the
body’s
neuroendocrine
response to
surgical stress
by blocking
transmission of
neuronal signals
to the central
nervous system.
Locoregional
anesthesia can
help preserve
natural killer
(NK) cell
function and
decrease the
amount of GA
required
intraoperatively.
PVB anesthesia
is associated
with lower risk
of cancer
recurrence.
Glissmyer, C.,
Johnson, W.,
Sherman, B.,
Glissmeyer, M.,
Garreau, J., &

Ninety-one patients
were included in this
study. The 51 patients
not having
reconstruction had an

Average LOS
was less (1.3
days) for the
reconstruction
group with PVB

Johnson, N.
(2015).

average morphine
equivalent (MSE) of
37.9. Of the 40 patients
undergoing
reconstruction, 33
received a PVB with an
average MSE 42.6, and
7 received only GA
with an average MSE
of 71.1.
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Karmakar, M.,
Samy, W., Li, J.,
Lee, A., Chan, W.,
Chen, P., & Ho, A.
(2014, July-Aug)

Parikh, Sharma,
Guffey, &
Myckatyn, (2016)

compared to the
reconstruction
group with no
PVB (2 days).

Patients who
receive a TPVB
report less severe
chronic pain,
exhibit fewer
symptoms and
signs of chronic
pain, and also
experience better
physical and mental
health related
quality of life
(HQROL).
Breast cancer patients
undergoing a
mastectomy with
autologous breast
reconstruction who
received a PVB were
needed less IV opioids

LOS was
significantly
less (mean of
95hrs) for the
PVB group
compared to the
non-PVB group
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postoperatively, were
converted to oral
narcotics sooner, and
had less pain at 2 and
24 hours compared to
the non-PVB group.
Pei, L., Zhou, Y.,
Patients receiving a
Tan, G., Mao, F.,
PVB with propofol
Yang, D., Guan, J., anesthesia required less
... Huang, Y.
sevoflurane, less
(2015, November
intraoperative fentanyl,
20).
and had less
postoperative pain than
patients who received
GA. However, patients
in the PVB with
propofol anesthesia
group required more
propofol than the GA
group.
Schnabel, A.,
There was significantly
Reichl, S. U.,
lower pain scores at
Kranke, P.,
rest in the 2-24 hour
Pogatzki-Zahn, E. period and lower pain
M., & Zhan, P. K. scores at movement for
(2010, October,
all time intervals in the
14).
group that received a
PVB in addition to GA
compared to the group
that received GA alone.

(mean of
116hrs).

Patients receiving
only a PVB had
less PONV than
women undergoing
surgery with GA.

Relative risk for
chronic pain was
lower in the PVB
group 6 months
after surgery.
Twelve months
after surgery two
studies reported a
lower chronic pain
when patients had a

Evidence
indicates
surgery can
release tumor
cells into
circulation,
volatile
anesthetics can
impair immune
function,

PVB in addition to
GA.

Forty-nine patients
were included in the
study. The dose of
remifentanil used

Patients who
reported chronic
pain had
significantly higher
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The number of patients
requiring postop
opioids was
significantly lower in
the PVB group.

Shimizu, H.,
Kamiya, Y.,
Nishimaki, H.,

opioids can
further impair
immune
function and
promote
angiogenic
factors, and
pain alone is
associated with
cancer
recurrence. This
study shows
patients
receiving a
PVB in addition
to GA or alone
required less
postoperative
pain
medications,
which could
indicate a
decreased
incidence of
cancer
recurrence.

Denda, S., &
Baba, H. (2015).
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Tahiri, Y., Tran,
D., Bouteaud, J.,
Xu, L., Lalonde,
D., Luc, M., &
Nikolis, A. (2011).

intraoperatively was
less in the PVB group.
Pain scores were
significantly lower 624 hours
postoperatively for
patients who received a
PVB. However, even
though pain scores
tended to be lower in
the PVB group, no
statistical significance
was found in pain
scores 0-6 hours after
surgery and 24 hours
after surgery.
Nine of the 11 studies
reported a complication
rate less than 2.6%.
The PVB group
reported less pain than
the general anesthetic
group, and
postoperative opioid
consumption was less
in the PVB group
compared to the
general anesthetic
group.

pain scores 3-6
hours
postoperatively.
The incidence of
chronic pain was
significantly less 1
year postop for the
PVB group (5/23)
compared to the
group receiving GA
alone (12/23).

Terkawi, A.,
Tsang, S., Sessler,
D., Terkawi, R.,
Nunemaker, M.,
Durieux, M., &
Shilling, A. (2015,
September/Octobe
r).
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Pain at rest and
movement was
modestly but
significantly less for
the PVB group at 2, 24,
48, and 72 hours after
surgery. The addition
of fentanyl to local
anesthetic decreased
pain with movement in
the PVB group at 24
and 72 hours.
Intraoperative and
postoperative opioid
use was significantly
less for those who
received a PVB
compared to the control
group with
heterogeneity.

A statistically
significant decrease
in PONV with
heterogeneity was
noted in the PVB
group.

Patients who
received a PVB
reported
significantly less
chronic pain at 6
months with no
heterogeneity
noted.

A statistically
significant
decrease in
LOS was found
for the PVB
group with
heterogeneity.

– Paravertebral Block Protocol
Candidates: Women diagnosed with breast cancer undergoing a bilateral mastectomy
with immediate reconstruction
Indication: To decrease postoperative pain, nausea/vomiting, and hospital length of stay
for patients undergoing a bilateral mastectomy with immediate reconstruction
Absolute Contraindications:
• Patient refusal
• Local anesthetic allergy
• Infection near injection site
• Tumor at injection site
• Severe hypovolemia
Relative Contraindications:
• Severe coagulopathy
• Severe respiratory disease
• Spinal deformities
• Unspecified neuropathy
Supplies:
• Emergency airway equipment
• Emergency drugs (including 20% intralipids)
• Ultrasound machine
• Nerve stimulator
• Sterile gloves
• Skin prep solution
• Lidocaine and 25-gauge needle for local injection
• 22-gauge nerve block needle or spinal needle
• 0.5% bupivacaine
• 1:200,000 epinephrine
Benefits:
• Postoperative pain control
• Decreased postoperative nausea/vomiting
• Decreased hospital length of stay
• Decreased incidence of chronic pain
Table A3
Paravertebral Block Protocol
Patient Preparation
• Verify patient name and date of
birth

•
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NIBP, O2saturation, HR, respiratory
rate, CBC

•

Obtain vital signs and review
pertinent lab work
Obtain informed consent

•
Process
• Premedicate patient with Versed (13 mg IV) and Fentanyl (25-100
mcg)
• Place patient in sitting position
• Ultrasound guided PVB at T1, T3,
and T5 using 0.5% bupivacaine
with 1:200,000 epinephrine.
o Inject 3-5ml at each level
bilaterally (not to exceed
30ml or 3mg/kg)

•

Include risks and benefits associated
procedure

•

Neck flexed with chin to chest,
shoulders in a collapsed position, and
back arched
Begin scanning 5-10 cm laterally to
identify ribs and pleura. Move
transducer medially until transverse
processes are identified. Once
transverse processes have been
identified, insert needle out-of-plane
until the transverse process is
contacted. Then, direct needle caudad
(approximately 1-1.5 cm) into the
paravertebral space. Aspirate and
inject 3-5 ml of local anesthetic.
Repeat this procedure for each level
to be blocked. Injection of local
anesthetic should result in
displacement of the pleura.
If a nerve stimulator is used begin
with current at 2-2.5mA with the goal
of eliciting an intercostal muscle
twitch. Observe twitch and decrease
mA to 0.8 while advancing needle
into paravertebral space.

•

•

Post Procedure Care
• Monitor patient for 30 minutes after
block for complications,
hypotension, and anesthetic
toxicity.
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– Initial Questionnaire
Initial Questionnaire
1. What is your age

2. What is your gender
□ Male
□ Female
3. How long have you been an anesthesia provider?

4. How many times did you provide anesthesia for a patient undergoing a bilateral
mastectomy with immediate reconstruction in the past month?

5. How many times did you perform a paravertebral block for these patients?

6. Of the patients undergoing a bilateral mastectomy with immediate reconstruction,
how many times was a paravertebral block contraindicated?

7. Was the information provided on paravertebral blocks relevant to your practice?
□
Yes
□
No
8. If a paravertebral block was performed (select all that apply)
□
For the majority of patients a paravertebral block was beneficial
□
A paravertebral block was not beneficial
□
Overall, the paravertebral blocks were easy to perform
□
The paravertebral blocks were not easy to perform
□
I will continue to administer paravertebral blocks for these patients
□
I will not continue to perform paravertebral blocks for these patients
□
Other
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– Follow-up Questionnaire
Follow-up Questionnaire
1. What is your age
2. What is your gender
□ Male
□ Female
3. How long have you been an anesthesia provider?
4. How many times did you provide anesthesia for a patient undergoing a bilateral
mastectomy with immediate reconstruction in the past month?
5. How many of these patients received a paravertebral block in addition to general
anesthesia?
6. How many of these patients received a pecs block in addition to general
anesthesia?
7. At what phase of patient care was the nerve block provided?
□
Preoperative
□
Intraoperative
□
Postoperative
8. Did the patients who received a nerve block experience less postoperative
complications than those who received only general anesthesia?
□
Yes
□
No
9. Was regional anesthesia used as the sole anesthetic for any of the patients
undergoing a bilateral mastectomy with immediate reconstruction?
□
Yes
□
No
10. Will you continue to perform nerve blocks for this patient population?
□
Yes
□
No
11. Of the patients undergoing a bilateral mastectomy with immediate reconstruction,
how many times was a nerve block contraindicated?
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– IRB Approval Letter
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– Facility Approval Letter
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– Logic Model
Table A4
Logic Model
Inputs

Facilities – OR
rooms
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Staff – CRNAs,
anesthesiologist,
surgeons
Equipment –
monitors,
emergency airway
equipment
Supplies –
equipment for
block, medications

Activities

Search databases
such as PubMed,
CINAHL, Primo at
The University of
Southern
Mississippi,
clinicaltrials.gov,
and MEDLINE
regarding different
methods of
administering
anesthesia for
patients undergoing
a bilateral
mastectomy with
immediate
reconstruction.
Collect data about
the postoperative

Outputs

Provide education
on the benefits of
PVBs to patients,
physicians, and
anesthesia staff
Implement a
policy for routine
administration of
PVBs for patients
undergoing a
bilateral
mastectomy with
immediate
reconstruction

Outcomes
Initial

Long-term

Impact

Provider
Outcomes
Anesthesia
providers will
adequately
administer PVBs
to patients
undergoing breast
surgery with
immediate
reconstruction

Provider
Outcomes
Anesthesia
providers will
routinely
administer PVBs
to patients
undergoing breast
surgery with
immediate
reconstruction

Improved quality
of life for
bilateral
mastectomy
patients having
immediate
reconstruction

Patient Outcomes
Patients have
decreased
postoperative
nausea and
vomiting
following surgery

Anesthesia
providers will
experience
satisfaction when
administering
PVBs to these
patients.

outcomes of
mastectomy
patients undergoing
a mastectomy with
immediate
reconstruction, like
the level of
postoperative pain,
nausea, and
vomiting
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Collect data about
the cost of different
methods of
anesthesia
Analyze data in
order to determine
if administration of
a PVB compared to
other methods of
anesthesia would
be beneficial and
cost effective for
mastectomy
patients undergoing
a bilateral
mastectomy with
immediate
reconstruction

when PVB are
used
Patients will be
discharged earlier

Hospital
Hospital
expenditure on
narcotics will
decrease
Revenue will
increase

Patient Outcomes
Long term –
Decreased
incidence of
chronic pain
Decreased
incidence of
cancer

Hospital
Decreased use of
medical
equipment and
earlier discharge
of patients will
decrease cost to
the hospital

Develop a policy to
implement PVBs
patients undergoing
a mastectomy with
immediate
reconstruction if
they are shown to
be beneficial
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Inform CRNAs
about online
training for
administration of
PVBs
Assumptions
-The postoperative care of bilateral mastectomy patients’ needs to be improved
- Patients will agree to have a PVB
- CRNAs will be authorized by the facility to administer PVBs
- Anesthesia providers will attend the in-service
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